Stoke Therapeutics, Inc. (STOK)
29.46
-0.62
(-2.06%)
USD |
NASDAQ |
May 18, 11:22
Stoke Therapeutics Shareholders Equity (Quarterly) : 394.88M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.65B |
| Krystal Biotech, Inc. | 1.277B |
| Scholar Rock Holding Corp. | 276.01M |
| Vertex Pharmaceuticals, Inc. | 19.36B |
| Zymeworks, Inc. | 163.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 443.28M |
| Total Liabilities (Quarterly) | 48.40M |
| Debt to Equity Ratio | 0.0087 |
| Current Ratio | 8.986 |
| Net Debt Paydown Yield | 0.01% |